ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,473.03
4.43%
S&P 500
5,641.87
0.47%
Dow Jones
40,258.75
0.64%
US Dollar vs Yen
157.919
-0.25%
Brent Oil
84.335
-0.31%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ritter Pharmaceuticals Inc (RTTR)

  7. Ritter Pharmaceuticals Inc (RTTR) ニュース

RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RTTR
日付受信時刻ニュースソース見出しコード企業名
2017/10/2404 : 43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/1805 : 19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/1205 : 07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/1106 : 25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/0504 : 58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/0402 : 32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/0401 : 00GlobeNewswire Inc.Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose IntoleranceNASDAQ:RTTRRitter Pharmaceuticals Inc
2017/10/0306 : 00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/2922 : 48Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/2921 : 00GlobeNewswire Inc.Ritter Pharmaceuticals, Inc. Prices $23,000,000 Public OfferingNASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/2919 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/2901 : 47Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/2819 : 13Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/1901 : 09Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/1602 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/1203 : 10Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/09/0805 : 58Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/2606 : 20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/1822 : 30MarketwiredRitter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose IntoleranceNASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/0919 : 11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/0719 : 18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/0719 : 18MarketwiredRitter Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business UpdateNASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/0506 : 26Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/08/0323 : 30MarketwiredRitter Pharmaceuticals Reports Further Analysis from its Phase 2b/3 Trial Results Demonstrating Significant Reductions in Lac...NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/07/2706 : 31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/07/2006 : 32Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/07/1822 : 13Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/07/1819 : 05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/07/0406 : 28Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RTTRRitter Pharmaceuticals Inc
2017/06/1005 : 33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RTTR

最近閲覧した銘柄

NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有